Mutation D30N Is Not Preferentially Selected by Human Immunodeficiency Virus Type 1 Subtype C in the Development of Resistance to Nelfinavir

Differences in baseline polymorphisms between subtypes may result in development of diverse mutational pathways during antiretroviral treatment. We compared drug resistance in patients with human immunodeficiency virus subtype C (referred to herein as “subtype-C-infected patients”) versus subtype-B-...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Grossman, Zehava, Paxinos, Ellen E., Averbuch, Diana, Maayan, Shlomo, Parkin, Neil T., Engelhard, Dan, Lorber, Margalit, Istomin, Valery, Shaked, Yael, Mendelson, Ella, Ram, Daniela, Petropoulos, Chris J., Schapiro, Jonathan M.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2004
Assuntos:	Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC415604/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15155216/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.6.2159-2165.2004
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!